• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非一家专门的青少年及青年成人肾脏诊所(KAYAC)的临床结果

Clinical Outcomes of a Dedicated Kidney Adolescent and Young Adult Clinic (KAYAC) in South Africa.

作者信息

Barday Zibya, Wearne Nicola, Jones Erika S W, McCulloch Mignon, Hoare Jacqueline, Manning Kathryn, Pretorius Suzanne, Davidson Bianca J

机构信息

Nephrology and Hypertension, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Paediatrics, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.

出版信息

Nephrology (Carlton). 2025 Sep;30(9):e70110. doi: 10.1111/nep.70110.

DOI:10.1111/nep.70110
PMID:40854568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12377949/
Abstract

AIM

Adolescents and young adults (AYAs) are increasingly utilising kidney health care services. However, there is no data on the impact of kidney transition clinics, as well as the AYA spectrum of kidney diseases, in South Africa (SA). This study evaluates kidney outcomes and patient survival amongst AYA patients attending a dedicated kidney AYA clinic (KAYAC).

METHODS

This 5-year retrospective study included AYA (aged 13-25) with kidney disease, attending a tertiary nephrology service. A comparative analysis of outcomes between patients who attended the KAYAC and those attending the standard-of-care adult kidney clinics was performed. The primary composite outcome assessed included doubling of creatinine, reduction in eGFR > 40%, kidney failure, requirement for kidney replacement therapy, or death. Logistic regression evaluated the associations between relevant variables, death, and loss to follow-up (LTFU).

RESULTS

The AYA cohort consisted of 292 patients: 111 (38.0%) attended KAYAC and 181 (62.0%) attended adult clinics. Glomerular diseases (72.6%), congenital urinary tract anomalies (10.6%) and hereditary conditions (8.2%) were the most common causes of kidney disease. The KAYAC group had delayed progression to kidney failure with an improved composite outcome (p = 0.018), lower mortality (p = 0.046) and less LTFU (p = 0.001). Both groups demonstrated high rates of non-adherence, with a prevalence of 33.9% in the total cohort.

CONCLUSION

AYA are a unique population who could benefit from KAYAC transition clinics. A dedicated KAYAC has been found to be associated with better kidney outcomes, lower mortality and less LTFU, underscoring its critical role in resource-limited settings.

摘要

目的

青少年和青年(AYA)对肾脏保健服务的利用越来越多。然而,在南非(SA),尚无关于肾脏过渡诊所的影响以及AYA肾脏疾病谱的数据。本研究评估了在专门的AYA肾脏诊所(KAYAC)就诊的AYA患者的肾脏结局和患者生存率。

方法

这项为期5年的回顾性研究纳入了患有肾脏疾病、在三级肾脏病服务机构就诊的AYA(年龄13 - 25岁)。对在KAYAC就诊的患者和在成人标准肾脏诊所就诊的患者的结局进行了比较分析。评估的主要复合结局包括肌酐翻倍、估算肾小球滤过率(eGFR)降低>40%、肾衰竭、肾脏替代治疗需求或死亡。逻辑回归评估了相关变量、死亡和失访(LTFU)之间的关联。

结果

AYA队列由292名患者组成:111名(38.0%)在KAYAC就诊,181名(62.0%)在成人诊所就诊。肾小球疾病(72.6%)、先天性尿路异常(10.6%)和遗传性疾病(8.2%)是肾脏疾病最常见的病因。KAYAC组进展至肾衰竭的时间延迟,复合结局改善(p = 0.018),死亡率较低(p = 0.046),LTFU较少(p = 0.001)。两组的不依从率都很高,在整个队列中的患病率为33.9%。

结论

AYA是一个独特的人群,可从KAYAC过渡诊所中受益。已发现专门的KAYAC与更好的肾脏结局、更低的死亡率和更少的LTFU相关,突显了其在资源有限环境中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f28/12377949/f38848a8f31e/NEP-30-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f28/12377949/f38848a8f31e/NEP-30-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f28/12377949/f38848a8f31e/NEP-30-0-g001.jpg

相似文献

1
Clinical Outcomes of a Dedicated Kidney Adolescent and Young Adult Clinic (KAYAC) in South Africa.南非一家专门的青少年及青年成人肾脏诊所(KAYAC)的临床结果
Nephrology (Carlton). 2025 Sep;30(9):e70110. doi: 10.1111/nep.70110.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Transition of care for adolescents from paediatric services to adult health services.青少年医疗护理从儿科服务向成人健康服务的过渡。
Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD009794. doi: 10.1002/14651858.CD009794.pub2.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.功能性运动障碍专科物理治疗的效果:Physio4FMD随机对照试验
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.

本文引用的文献

1
Kidney adolescent and young adult clinic: A transition model in Africa.青少年与青年肾脏科:非洲的一种过渡模式。
Pediatr Transplant. 2024 Mar;28(2):e14690. doi: 10.1111/petr.14690.
2
Better Together: acceptability, feasibility and preliminary impact of chronic illness peer support groups for South African adolescents and young adults.携手同行:南非青少年和青年群体慢性病同伴支持小组的可接受性、可行性和初步影响。
J Int AIDS Soc. 2023 Oct;26 Suppl 4(Suppl 4):e26148. doi: 10.1002/jia2.26148.
3
Predictors of loss to follow up from antiretroviral therapy among adolescents with HIV/AIDS in Tanzania.
坦桑尼亚 HIV/AIDS 青少年接受抗逆转录病毒治疗后随访失败的预测因素。
PLoS One. 2022 Jul 20;17(7):e0268825. doi: 10.1371/journal.pone.0268825. eCollection 2022.
4
Transitional care models in adolescent kidney transplant recipients-a systematic review.青少年肾移植受者过渡期护理模式的系统评价。
Nephrol Dial Transplant. 2023 Jan 23;38(1):49-55. doi: 10.1093/ndt/gfac175.
5
Discontinuation of follow-up care for young people with complex chronic conditions: conceptual definitions and operational components.年轻人患有复杂慢性疾病时停止后续护理:概念定义和操作组成部分。
BMC Health Serv Res. 2021 Dec 15;21(1):1343. doi: 10.1186/s12913-021-07335-x.
6
Factors associated with graft survival in South African adolescent renal transplant patients at CMJAH over a 20-year period (GRAFT-SAT Study).在 20 年期间,与南非青少年肾移植患者在 CMJAH 的移植物存活率相关的因素(GRAFT-SAT 研究)。
Pediatr Transplant. 2022 Feb;26(1):e14148. doi: 10.1111/petr.14148. Epub 2021 Sep 27.
7
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
8
Prediction of mortality among patients with chronic kidney disease: A systematic review.慢性肾病患者死亡率的预测:一项系统综述。
World J Nephrol. 2021 Jul 25;10(4):59-75. doi: 10.5527/wjn.v10.i4.59.
9
Paediatric to adult healthcare transition in resource-limited settings: a narrative review.资源有限环境下儿科至成人医疗保健的过渡:叙事性综述。
BMJ Paediatr Open. 2021 Apr 19;5(1):e001059. doi: 10.1136/bmjpo-2021-001059. eCollection 2021.
10
International consensus definitions of clinical trial outcomes for kidney failure: 2020.2020年肾衰竭临床试验结果的国际共识定义。
Kidney Int. 2020 Oct;98(4):849-859. doi: 10.1016/j.kint.2020.07.013.